GE Healthcare has named Mark Kramer, former director of the Office of Combination Products at the U.S. Food and Drug Administration (FDA), as vice president, Regulatory Affairs. Kramer has more than 17 years of experience from the FDA, as well as insight on regulatory affairs and quality compliance relating to product development.

In his new position, Kramer will lead the regulatory function for GE Healthcare and will work closely with global regulatory bodies to formulate strategic business plans.

 “As GE continues to develop innovative technologies that improve the entire patient experience, from early and more accurate diagnosis to better treatment and management of disease, Mark will provide the leadership that is necessary to ensure compliant best practices in the regulatory process,” said Dee Mellor, GE Healthcare’s chief quality officer.